Fredun Pharmaceuticals

quarterly
yearly
ParticularsDec '21Mar '22Jun '22Sep '22Dec '22
Revenue54.2370.2248.2569.0677.93
Expenses50.4367.0345.2064.2571.38
EBITDA3.803.193.054.816.55
EBIT3.252.612.404.095.81
Profit Before Tax2.563.091.314.214.62
Net Profit1.872.300.943.153.46
Financial Ratios
Operating Profit Margin7.03%4.53%6.32%6.96%8.40%
Net Profit Margin3.45%3.28%1.95%4.56%4.44%
Earning Per Share (Diluted)4.224.092.127.117.66
Dividends Per ShareNA0.70NANANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.8.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI